Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Longboard Pharmaceuticals Inc (NQ: LBPH ) 59.50 -0.19 (-0.32%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,701,718 Open 59.66 Bid (Size) 59.41 (2) Ask (Size) 59.95 (10) Prev. Close 59.69 Today's Range 58.82 - 59.70 52wk Range 3.600 - 59.95 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc. - LBPH October 31, 2024 From Kahn Swick & Foti, LLC Via Business Wire Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags October 21, 2024 S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day. Via Benzinga Topics Bankruptcy Stocks Exposures Financial Legal US Equities Performance YTD +137.05% +137.05% 1 Month +78.41% +78.41% 3 Month +74.03% +74.03% 6 Month +188.83% +188.83% 1 Year +1035.50% +1035.50% More News Read More Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? October 20, 2024 Via Benzinga SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LBPH and ARC on Behalf of Shareholders October 17, 2024 From Halper Sadeh LLC Via GlobeNewswire Bright Minds Biosciences Stock Surges Almost 1,500% October 16, 2024 Via MarketBeat LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc. - LBPH October 15, 2024 From Kahn Swick & Foti, LLC Via Business Wire Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump October 14, 2024 Via Benzinga Topics Stocks Exposures US Equities NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday October 14, 2024 Via Benzinga Topics Government Exposures Political 12 Health Care Stocks Moving In Monday's Intraday Session October 14, 2024 Via Benzinga Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record October 14, 2024 Via Investor's Business Daily Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? October 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session October 14, 2024 Via Benzinga Shareholder Alert: Ademi LLP Investigates Whether Longboard Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public Shareholders October 14, 2024 From Ademi LLP Via Business Wire LBPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Longboard Pharmaceuticals, Inc. Is Fair to Shareholders October 14, 2024 From Halper Sadeh LLC Via Business Wire Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket October 14, 2024 Via Benzinga Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline October 14, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) October 04, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study Evaluating Bexicaserin in Dravet Syndrome September 26, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Receives Rare Pediatric Disease Designation and Orphan Drug Designation for Bexicaserin (LP352) in Dravet Syndrome September 19, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday September 18, 2024 Via Benzinga Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage September 10, 2024 Via Benzinga Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs) September 08, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) September 06, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals to Participate in Four Upcoming Investor Conferences in September August 28, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals to Present Late-Breaking and Encore Data at the 15th European Epilepsy Congress August 26, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
